 | • レポートコード：D005-07472 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、緑内障治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。緑内障治療薬の種類別市場規模（プロスタグランジン類似体、ベータブロッカー、アルファアゴニスト、炭酸脱水酵素阻害剤、併用薬）、用途別市場規模（開放隅角緑内障、閉塞隅角緑内障）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、SANDOZ、Laboratoire Riva、Novartis、Teva Pharmaceutical?、bausch Lomb、Mylan、Fresenius、Jamp Pharma、Greenstone、Actavis、GE Medical、APOTEX、Taj Pharmaceuticals、Mint Pharmaceuticals、Sun Pharma、Laboratoires Thea ・地域別グローバル市場分析 2015年-2020年 ・緑内障治療薬の北米市場（アメリカ、カナダ、メキシコ） ・緑内障治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・緑内障治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・緑内障治療薬の南米市場（ブラジル、アルゼンチン） ・緑内障治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：プロスタグランジン類似体、ベータブロッカー、アルファアゴニスト、炭酸脱水酵素阻害剤、併用薬 ・用途別分析：開放隅角緑内障、閉塞隅角緑内障 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Glaucoma Medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Glaucoma Medications market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Glaucoma Medications market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Glaucoma Medications market has been segmented into
Prostaglandin Analogs
Beta Blockers
Alpha Agonists
Carbonic Anhydrase Inhibitors
Combined Medications
By Application, Glaucoma Medications has been segmented into:
Open-angle Glaucoma
Closed-angle Glaucoma
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Glaucoma Medications market presented in the report. This section sheds light on the sales growth of different regional and country-level Glaucoma Medications markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Glaucoma Medications market.
The report offers in-depth assessment of the growth and other aspects of the Glaucoma Medications market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Glaucoma Medications Market Share Analysis
Glaucoma Medications competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Glaucoma Medications sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Glaucoma Medications sales, revenue and market share for each player covered in this report.
The major players covered in Glaucoma Medications are:
Pfizer
SANDOZ
Laboratoire Riva
Novartis
Teva Pharmaceutical?
bausch Lomb
Mylan
Fresenius
Jamp Pharma
Greenstone
Actavis
GE Medical
APOTEX
Taj Pharmaceuticals
Mint Pharmaceuticals
Sun Pharma
Laboratoires Thea
Among other players domestic and global, Glaucoma Medications market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glaucoma Medications product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Glaucoma Medications, with price, sales, revenue and global market share of Glaucoma Medications in 2018 and 2019.
Chapter 3, the Glaucoma Medications competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glaucoma Medications breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Glaucoma Medications market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Glaucoma Medications sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Glaucoma Medications Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Glaucoma Medications Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Prostaglandin Analogs
1.2.3 Beta Blockers
1.2.4 Alpha Agonists
1.2.5 Carbonic Anhydrase Inhibitors
1.2.6 Combined Medications
1.3 Market Analysis by Application
1.3.1 Overview: Global Glaucoma Medications Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Open-angle Glaucoma
1.3.3 Closed-angle Glaucoma
1.4 Overview of Global Glaucoma Medications Market
1.4.1 Global Glaucoma Medications Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 SANDOZ
2.2.1 SANDOZ Details
2.2.2 SANDOZ Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 SANDOZ SWOT Analysis
2.2.4 SANDOZ Product and Services
2.2.5 SANDOZ Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Laboratoire Riva
2.3.1 Laboratoire Riva Details
2.3.2 Laboratoire Riva Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Laboratoire Riva SWOT Analysis
2.3.4 Laboratoire Riva Product and Services
2.3.5 Laboratoire Riva Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Teva Pharmaceutical?
2.5.1 Teva Pharmaceutical? Details
2.5.2 Teva Pharmaceutical? Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Teva Pharmaceutical? SWOT Analysis
2.5.4 Teva Pharmaceutical? Product and Services
2.5.5 Teva Pharmaceutical? Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 bausch Lomb
2.6.1 bausch Lomb Details
2.6.2 bausch Lomb Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 bausch Lomb SWOT Analysis
2.6.4 bausch Lomb Product and Services
2.6.5 bausch Lomb Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Mylan SWOT Analysis
2.7.4 Mylan Product and Services
2.7.5 Mylan Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Fresenius
2.8.1 Fresenius Details
2.8.2 Fresenius Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Fresenius SWOT Analysis
2.8.4 Fresenius Product and Services
2.8.5 Fresenius Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Jamp Pharma
2.9.1 Jamp Pharma Details
2.9.2 Jamp Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Jamp Pharma SWOT Analysis
2.9.4 Jamp Pharma Product and Services
2.9.5 Jamp Pharma Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Greenstone
2.10.1 Greenstone Details
2.10.2 Greenstone Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Greenstone SWOT Analysis
2.10.4 Greenstone Product and Services
2.10.5 Greenstone Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Actavis
2.11.1 Actavis Details
2.11.2 Actavis Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Actavis SWOT Analysis
2.11.4 Actavis Product and Services
2.11.5 Actavis Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 GE Medical
2.12.1 GE Medical Details
2.12.2 GE Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 GE Medical SWOT Analysis
2.12.4 GE Medical Product and Services
2.12.5 GE Medical Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 APOTEX
2.13.1 APOTEX Details
2.13.2 APOTEX Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 APOTEX SWOT Analysis
2.13.4 APOTEX Product and Services
2.13.5 APOTEX Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Taj Pharmaceuticals
2.14.1 Taj Pharmaceuticals Details
2.14.2 Taj Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Taj Pharmaceuticals SWOT Analysis
2.14.4 Taj Pharmaceuticals Product and Services
2.14.5 Taj Pharmaceuticals Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Mint Pharmaceuticals
2.15.1 Mint Pharmaceuticals Details
2.15.2 Mint Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Mint Pharmaceuticals SWOT Analysis
2.15.4 Mint Pharmaceuticals Product and Services
2.15.5 Mint Pharmaceuticals Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Sun Pharma
2.16.1 Sun Pharma Details
2.16.2 Sun Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Sun Pharma SWOT Analysis
2.16.4 Sun Pharma Product and Services
2.16.5 Sun Pharma Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Laboratoires Thea
2.17.1 Laboratoires Thea Details
2.17.2 Laboratoires Thea Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Laboratoires Thea SWOT Analysis
2.17.4 Laboratoires Thea Product and Services
2.17.5 Laboratoires Thea Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Glaucoma Medications Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Glaucoma Medications Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Glaucoma Medications Manufacturer Market Share in 2019
3.3.2 Top 6 Glaucoma Medications Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Glaucoma Medications Sales, Revenue and Market Share by Regions
4.1.1 Global Glaucoma Medications Sales and Market Share by Regions (2015-2020)
4.1.2 Global Glaucoma Medications Revenue and Market Share by Regions (2015-2020)
4.2 North America Glaucoma Medications Sales and Growth Rate (2015-2020)
4.3 Europe Glaucoma Medications Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Glaucoma Medications Sales and Growth Rate (2015-2020)
4.5 South America Glaucoma Medications Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Glaucoma Medications Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Glaucoma Medications Sales, Revenue and Market Share by Country
5.1.1 North America Glaucoma Medications Sales and Market Share by Country (2015-2020)
5.1.2 North America Glaucoma Medications Revenue and Market Share by Country (2015-2020)
5.2 United States Glaucoma Medications Sales and Growth Rate (2015-2020)
5.3 Canada Glaucoma Medications Sales and Growth Rate (2015-2020)
5.4 Mexico Glaucoma Medications Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Glaucoma Medications Sales, Revenue and Market Share by Country
6.1.1 Europe Glaucoma Medications Sales and Market Share by Country (2015-2020)
6.1.2 Europe Glaucoma Medications Revenue and Market Share by Country (2015-2020)
6.2 Germany Glaucoma Medications Sales and Growth Rate (2015-2020)
6.3 UK Glaucoma Medications Sales and Growth Rate (2015-2020)
6.4 France Glaucoma Medications Sales and Growth Rate (2015-2020)
6.5 Russia Glaucoma Medications Sales and Growth Rate (2015-2020)
6.6 Italy Glaucoma Medications Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Glaucoma Medications Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Glaucoma Medications Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Glaucoma Medications Revenue and Market Share by Regions (2015-2020)
7.2 China Glaucoma Medications Sales and Growth Rate (2015-2020)
7.3 Japan Glaucoma Medications Sales and Growth Rate (2015-2020)
7.4 Korea Glaucoma Medications Sales and Growth Rate (2015-2020)
7.5 India Glaucoma Medications Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Glaucoma Medications Sales and Growth Rate (2015-2020)
7.7 Australia Glaucoma Medications Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Glaucoma Medications Sales, Revenue and Market Share by Country
8.1.1 South America Glaucoma Medications Sales and Market Share by Country (2015-2020)
8.1.2 South America Glaucoma Medications Revenue and Market Share by Country (2015-2020)
8.2 Brazil Glaucoma Medications Sales and Growth Rate (2015-2020)
8.3 Argentina Glaucoma Medications Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Glaucoma Medications Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Glaucoma Medications Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Glaucoma Medications Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Glaucoma Medications Sales and Growth Rate (2015-2020)
9.3 Turkey Glaucoma Medications Sales and Growth Rate (2015-2020)
9.4 Egypt Glaucoma Medications Sales and Growth Rate (2015-2020)
9.5 South Africa Glaucoma Medications Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Glaucoma Medications Sales and Market Share by Type (2015-2020)
10.2 Global Glaucoma Medications Revenue and Market Share by Type (2015-2020)
10.3 Global Glaucoma Medications Price by Type (2015-2020)
11 Global Glaucoma Medications Market Segment by Application
11.1 Global Glaucoma Medications Sales Market Share by Application (2015-2020)
11.2 Global Glaucoma Medications Revenue Market Share by Application (2015-2020)
11.3 Global Glaucoma Medications Price by Application (2015-2020)
12 Market Forecast
12.1 Global Glaucoma Medications Sales, Revenue and Growth Rate (2021-2025)
12.2 Glaucoma Medications Market Forecast by Regions (2021-2025)
12.2.1 North America Glaucoma Medications Market Forecast (2021-2025)
12.2.2 Europe Glaucoma Medications Market Forecast (2021-2025)
12.2.3 Asia-Pacific Glaucoma Medications Market Forecast (2021-2025)
12.2.4 South America Glaucoma Medications Market Forecast (2021-2025)
12.2.5 Middle East & Africa Glaucoma Medications Market Forecast (2021-2025)
12.3 Glaucoma Medications Market Forecast by Type (2021-2025)
12.3.1 Global Glaucoma Medications Sales Forecast by Type (2021-2025)
12.3.2 Global Glaucoma Medications Market Share Forecast by Type (2021-2025)
12.4 Glaucoma Medications Market Forecast by Application (2021-2025)
12.4.1 Global Glaucoma Medications Sales Forecast by Application (2021-2025)
12.4.2 Global Glaucoma Medications Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Glaucoma Medications Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Glaucoma Medications by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Glaucoma Medications Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Glaucoma Medications Major Business
Table 9. Pfizer Glaucoma Medications Total Revenue (USD Million) (2017-2018)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer Glaucoma Medications Product and Services
Table 12. Pfizer Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. SANDOZ Basic Information, Manufacturing Base and Competitors
Table 14. SANDOZ Glaucoma Medications Major Business
Table 15. SANDOZ Glaucoma Medications Total Revenue (USD Million) (2017-2018)
Table 16. SANDOZ SWOT Analysis
Table 17. SANDOZ Glaucoma Medications Product and Services
Table 18. SANDOZ Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Laboratoire Riva Basic Information, Manufacturing Base and Competitors
Table 20. Laboratoire Riva Glaucoma Medications Major Business
Table 21. Laboratoire Riva Glaucoma Medications Total Revenue (USD Million) (2017-2018)
Table 22. Laboratoire Riva SWOT Analysis
Table 23. Laboratoire Riva Glaucoma Medications Product and Services
Table 24. Laboratoire Riva Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis Basic Information, Manufacturing Base and Competitors
Table 26. Novartis Glaucoma Medications Major Business
Table 27. Novartis Glaucoma Medications Total Revenue (USD Million) (2017-2018)
Table 28. Novartis SWOT Analysis
Table 29. Novartis Glaucoma Medications Product and Services
Table 30. Novartis Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Teva Pharmaceutical? Basic Information, Manufacturing Base and Competitors
Table 32. Teva Pharmaceutical? Glaucoma Medications Major Business
Table 33. Teva Pharmaceutical? Glaucoma Medications Total Revenue (USD Million) (2017-2018)
Table 34. Teva Pharmaceutical? SWOT Analysis
Table 35. Teva Pharmaceutical? Glaucoma Medications Product and Services
Table 36. Teva Pharmaceutical? Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. bausch Lomb Basic Information, Manufacturing Base and Competitors
Table 38. bausch Lomb Glaucoma Medications Major Business
Table 39. bausch Lomb Glaucoma Medications Total Revenue (USD Million) (2017-2018)
Table 40. bausch Lomb SWOT Analysis
Table 41. bausch Lomb Glaucoma Medications Product and Services
Table 42. bausch Lomb Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Mylan Basic Information, Manufacturing Base and Competitors
Table 44. Mylan Glaucoma Medications Major Business
Table 45. Mylan Glaucoma Medications Total Revenue (USD Million) (2017-2018)
Table 46. Mylan SWOT Analysis
Table 47. Mylan Glaucoma Medications Product and Services
Table 48. Mylan Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Fresenius Basic Information, Manufacturing Base and Competitors
Table 50. Fresenius Glaucoma Medications Major Business
Table 51. Fresenius Glaucoma Medications Total Revenue (USD Million) (2017-2018)
Table 52. Fresenius SWOT Analysis
Table 53. Fresenius Glaucoma Medications Product and Services
Table 54. Fresenius Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Jamp Pharma Basic Information, Manufacturing Base and Competitors
Table 56. Jamp Pharma Glaucoma Medications Major Business
Table 57. Jamp Pharma Glaucoma Medications Total Revenue (USD Million) (2017-2018)
Table 58. Jamp Pharma SWOT Analysis
Table 59. Jamp Pharma Glaucoma Medications Product and Services
Table 60. Jamp Pharma Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Greenstone Basic Information, Manufacturing Base and Competitors
Table 62. Greenstone Glaucoma Medications Major Business
Table 63. Greenstone Glaucoma Medications Total Revenue (USD Million) (2017-2018)
Table 64. Greenstone SWOT Analysis
Table 65. Greenstone Glaucoma Medications Product and Services
Table 66. Greenstone Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Actavis Basic Information, Manufacturing Base and Competitors
Table 68. Actavis Glaucoma Medications Major Business
Table 69. Actavis Glaucoma Medications Total Revenue (USD Million) (2017-2018)
Table 70. Actavis SWOT Analysis
Table 71. Actavis Glaucoma Medications Product and Services
Table 72. Actavis Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. GE Medical Basic Information, Manufacturing Base and Competitors
Table 74. GE Medical Glaucoma Medications Major Business
Table 75. GE Medical Glaucoma Medications Total Revenue (USD Million) (2017-2018)
Table 76. GE Medical SWOT Analysis
Table 77. GE Medical Glaucoma Medications Product and Services
Table 78. GE Medical Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. APOTEX Basic Information, Manufacturing Base and Competitors
Table 80. APOTEX Glaucoma Medications Major Business
Table 81. APOTEX Glaucoma Medications Total Revenue (USD Million) (2017-2018)
Table 82. APOTEX SWOT Analysis
Table 83. APOTEX Glaucoma Medications Product and Services
Table 84. APOTEX Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Taj Pharmaceuticals Glaucoma Medications Major Business
Table 87. Taj Pharmaceuticals Glaucoma Medications Total Revenue (USD Million) (2017-2018)
Table 88. Taj Pharmaceuticals SWOT Analysis
Table 89. Taj Pharmaceuticals Glaucoma Medications Product and Services
Table 90. Taj Pharmaceuticals Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Mint Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Mint Pharmaceuticals Glaucoma Medications Major Business
Table 93. Mint Pharmaceuticals Glaucoma Medications Total Revenue (USD Million) (2017-2018)
Table 94. Mint Pharmaceuticals SWOT Analysis
Table 95. Mint Pharmaceuticals Glaucoma Medications Product and Services
Table 96. Mint Pharmaceuticals Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 98. Sun Pharma Glaucoma Medications Major Business
Table 99. Sun Pharma Glaucoma Medications Total Revenue (USD Million) (2017-2018)
Table 100. Sun Pharma SWOT Analysis
Table 101. Sun Pharma Glaucoma Medications Product and Services
Table 102. Sun Pharma Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Laboratoires Thea Basic Information, Manufacturing Base and Competitors
Table 104. Laboratoires Thea Glaucoma Medications Major Business
Table 105. Laboratoires Thea Glaucoma Medications Total Revenue (USD Million) (2017-2018)
Table 106. Laboratoires Thea SWOT Analysis
Table 107. Laboratoires Thea Glaucoma Medications Product and Services
Table 108. Laboratoires Thea Glaucoma Medications Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Global Glaucoma Medications Sales by Manufacturer (2018-2019) (MT)
Table 110. Global Glaucoma Medications Revenue by Manufacturer (2018-2019) (USD Million)
Table 111. Global Glaucoma Medications Sales by Regions (2015-2020) (MT)
Table 112. Global Glaucoma Medications Sales Market Share by Regions (2015-2020)
Table 113. Global Glaucoma Medications Revenue by Regions (2015-2020) (USD Million)
Table 114. North America Glaucoma Medications Sales by Countries (2015-2020) (MT)
Table 115. North America Glaucoma Medications Sales Market Share by Countries (2015-2020)
Table 116. North America Glaucoma Medications Revenue by Countries (2015-2020) (USD Million)
Table 117. North America Glaucoma Medications Revenue Market Share by Countries (2015-2020)
Table 118. Europe Glaucoma Medications Sales by Countries (2015-2020) (MT)
Table 119. Europe Glaucoma Medications Sales Market Share by Countries (2015-2020)
Table 120. Europe Glaucoma Medications Revenue by Countries (2015-2020) (USD Million)
Table 121. Asia-Pacific Glaucoma Medications Sales by Regions (2015-2020) (MT)
Table 122. Asia-Pacific Glaucoma Medications Sales Market Share by Regions (2015-2020)
Table 123. Asia-Pacific Glaucoma Medications Revenue by Regions (2015-2020) (USD Million)
Table 124. South America Glaucoma Medications Sales by Countries (2015-2020) (MT)
Table 125. South America Glaucoma Medications Sales Market Share by Countries (2015-2020)
Table 126. South America Glaucoma Medications Revenue by Countries (2015-2020) (USD Million)
Table 127. South America Glaucoma Medications Revenue Market Share by Countries (2015-2020)
Table 128. Middle East & Africa Glaucoma Medications Sales by Countries (2015-2020) (MT)
Table 129. Middle East & Africa Glaucoma Medications Sales Market Share by Countries (2015-2020)
Table 130. Middle East & Africa Glaucoma Medications Revenue by Countries (2015-2020) (USD Million)
Table 131. Middle East & Africa Glaucoma Medications Revenue Market Share by Countries (2015-2020)
Table 132. Global Glaucoma Medications Sales by Type (2015-2020) (MT)
Table 133. Global Glaucoma Medications Sales Share by Type (2015-2020)
Table 134. Global Glaucoma Medications Revenue by Type (2015-2020) (USD Million)
Table 135. Global Glaucoma Medications Revenue Share by Type (2015-2020)
Table 136. Global Glaucoma Medications Sales by Application (2015-2020) (MT)
Table 137. Global Glaucoma Medications Sales Share by Application (2015-2020)
Table 138. Global Glaucoma Medications Sales Forecast by Regions (2021-2025) (MT)
Table 139. Global Glaucoma Medications Market Share Forecast by Regions (2021-2025)
Table 140. Global Glaucoma Medications Sales Forecast by Type (2021-2025) (MT)
Table 141. Global Glaucoma Medications Market Share Forecast by Type (2021-2025)
Table 142. Global Glaucoma Medications Sales Forecast by Application (2021-2025)
Table 143. Global Glaucoma Medications Market Share Forecast by Application (2021-2025)
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Glaucoma Medications Picture
Figure 2. Global Sales Market Share of Glaucoma Medications by Type in 2019
Figure 3. Prostaglandin Analogs Picture
Figure 4. Beta Blockers Picture
Figure 5. Alpha Agonists Picture
Figure 6. Carbonic Anhydrase Inhibitors Picture
Figure 7. Combined Medications Picture
Figure 8. Glaucoma Medications Sales Market Share by Application in 2018
Figure 9. Open-angle Glaucoma Picture
Figure 10. Closed-angle Glaucoma Picture
Figure 11. Global Glaucoma Medications Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Glaucoma Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Glaucoma Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Glaucoma Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Glaucoma Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Glaucoma Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Glaucoma Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Glaucoma Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Glaucoma Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Glaucoma Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Glaucoma Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Glaucoma Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Glaucoma Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Glaucoma Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Glaucoma Medications Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Glaucoma Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Glaucoma Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Glaucoma Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Glaucoma Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Glaucoma Medications Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Glaucoma Medications Sales Market Share by Manufacturer in 2019
Figure 32. Global Glaucoma Medications Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Glaucoma Medications Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Glaucoma Medications Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Glaucoma Medications Sales and Growth Rate (2015-2020) (MT)
Figure 37. Global Glaucoma Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Glaucoma Medications Revenue Market Share by Regions (2015-2020)
Figure 39. Global Glaucoma Medications Revenue Market Share by Regions in 2018
Figure 40. North America Glaucoma Medications Sales and Growth Rate (2015-2020)
Figure 41. Europe Glaucoma Medications Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Glaucoma Medications Sales and Growth Rate (2015-2020)
Figure 43. South America Glaucoma Medications Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Glaucoma Medications Sales and Growth Rate (2015-2020)
Figure 45. North America Glaucoma Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Glaucoma Medications Sales Market Share by Countries (2015-2020)
Figure 47. North America Glaucoma Medications Sales Market Share by Countries in 2018
Figure 48. North America Glaucoma Medications Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Glaucoma Medications Revenue Market Share by Countries in 2018
Figure 50. United States Glaucoma Medications Sales and Growth Rate (2015-2020) (MT)
Figure 51. Canada Glaucoma Medications Sales and Growth Rate (2015-2020) (MT)
Figure 52. Mexico Glaucoma Medications Sales and Growth Rate (2015-2020) (MT)
Figure 53. Europe Glaucoma Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Glaucoma Medications Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Glaucoma Medications Revenue Market Share by Countries in 2019
Figure 56. Germany Glaucoma Medications Sales and Growth Rate (2015-2020) (MT)
Figure 57. UK Glaucoma Medications Sales and Growth Rate (2015-2020) (MT)
Figure 58. France Glaucoma Medications Sales and Growth Rate (2015-2020) (MT)
Figure 59. Russia Glaucoma Medications Sales and Growth Rate (2015-2020) (MT)
Figure 60. Italy Glaucoma Medications Sales and Growth Rate (2015-2020) (MT)
Figure 61. Asia-Pacific Glaucoma Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Glaucoma Medications Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Glaucoma Medications Revenue Market Share by Regions 2019
Figure 64. China Glaucoma Medications Sales and Growth Rate (2015-2020) (MT)
Figure 65. Japan Glaucoma Medications Sales and Growth Rate (2015-2020) (MT)
Figure 66. Korea Glaucoma Medications Sales and Growth Rate (2015-2020) (MT)
Figure 67. India Glaucoma Medications Sales and Growth Rate (2015-2020) (MT)
Figure 68. Southeast Asia Glaucoma Medications Sales and Growth Rate (2015-2020) (MT)
Figure 69. South America Glaucoma Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Glaucoma Medications Sales Market Share by Countries in 2019
Figure 71. South America Glaucoma Medications Revenue Market Share by Countries in 2019
Figure 72. Brazil Glaucoma Medications Sales and Growth Rate (2015-2020) (MT)
Figure 73. Argentina Glaucoma Medications Sales and Growth Rate (2015-2020) (MT)
Figure 74. Middle East and Africa Glaucoma Medications Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Glaucoma Medications Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Glaucoma Medications Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Glaucoma Medications Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Glaucoma Medications Sales and Growth Rate (2015-2020) (MT)
Figure 79. Egypt Glaucoma Medications Sales and Growth Rate (2015-2020) (MT)
Figure 80. Turkey Glaucoma Medications Sales and Growth Rate (2015-2020) (MT)
Figure 81. South Africa Glaucoma Medications Sales and Growth Rate (2015-2020) (MT)
Figure 82. Global Glaucoma Medications Sales and Growth Rate (2021-2025) (MT)
Figure 83. Global Glaucoma Medications Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Glaucoma Medications Market Forecast (2021-2025) (MT)
Figure 85. Europe Sales Glaucoma Medications Market Forecast (2021-2025) (MT)
Figure 86. Asia-Pacific Sales Glaucoma Medications Market Forecast (2021-2025) (MT)
Figure 87. South America Sales Glaucoma Medications Market Forecast (2021-2025) (MT)
Figure 88. Middle East & Africa Sales Glaucoma Medications Market Forecast (2021-2025) (MT)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
緑内障ドレナージバルブの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Glaucoma Drainage Valve market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Glaucoma Drainage Val…- 緑内障手術デバイスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Glaucoma Surgery Device market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Glaucoma Surgery Devi…
- 皮膚科用OTC薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Dermatology OTC medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dermatology OTC m…
- 単一角度光沢計の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Single Angle Glossmeters market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Single Angle Glossme…
- ブロンズアングルバルブの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Bronze Angle Valves market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bronze Angle Valves marke…